Fresenius Medical Care AG
SWB:FMEA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of 
Fresenius Medical Care AG (FMEA) under the Base Case is EUR per share.
Compared with the current market price of 20.6 EUR, the stock appears .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Intrinsic value next to the price over the past 5 years, and what happened after valuations like today’s.
Create a free account · No card needed
Fundamental Analysis
What Fresenius Medical Care Does
Fresenius Medical Care AG is one of the world’s main kidney care companies. It treats patients with chronic kidney failure by running dialysis clinics and by providing dialysis treatments in hospitals and care centers. It also sells the equipment, filters, and related supplies needed to deliver dialysis, which makes it both a care provider and a medical products supplier.
- Headquarters
- Germany DE
- Employees
- 123 106
- IPO date
- Oct 2, 1996
Fresenius Medical Care has no economic moat
In much of the U.S., government reimbursement and competition based on care quality, access, and physician referrals leave little evidence that the Fresenius name lets the company charge more. Patients and doctors can choose other dialysis providers, and Fresenius’s scale does not make its services more valuable simply because more people use them.
Read the full moat analysis
Revenue & Expenses Breakdown
Fresenius Medical Care AG
Earnings Waterfall
Fresenius Medical Care AG
What is the Intrinsic Value of one FMEA stock?
The intrinsic value for Fresenius Medical Care AG (FMEA) under the Base Case is EUR.
Is FMEA stock undervalued or overvalued?
Compared with the current market price of 20.6 EUR, the stock appears .
